GlassScriptPhysician profile
Sana Malik
NPI 1164793410
$9,607.91
in general payments reported to CMS, 2019-2025
26 companies · $2,006 in 2025
The $2,006 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $1,345 · 2021: $1,160 · 2022: $1,748 · 2023: $1,458 · 2024: $1,140 · 2025: $2,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,443 · Entertainment: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,443.39 |
| Entertainment | $160.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,701.69 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Carl Zeiss Meditec, INC. | $1,150.00 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $931.14 | 2019-2024 | Acuvue |
| Optos, INC. | $657.97 | 2021-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $572.27 | 2023-2025 | Xiidra, Miebo, Infuse |
| Sun Pharmaceutical Industries INC. | $466.86 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $293.74 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $261.07 | 2019-2020 | |
| Biotissue Holdings INC. | $249.74 | 2023-2024 | |
| Lkc Technologies, INC. | $242.12 | 2024-2025 | |
| Glaukos Corporation | $217.03 | 2025 | Photrexa Viscous and Photrexa |
| Shire North American Group INC | $215.49 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $210.34 | 2025 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $191.24 | 2019-2023 | Contact Lens, Spectacle Lenses |
| Dompe US, INC. | $183.04 | 2023-2025 | Oxervate |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $167.25 | 2023-2025 | Myday Contact Lens, Misight Contact Lens |
| Sight Sciences, INC. | $158.60 | 2024 | Tearcare System |
| Amgen INC. | $124.97 | 2024 | Tepezza |
| Astellas Pharma US INC | $121.86 | 2025 | Izervay |
| Horizon Therapeutics Plc | $120.78 | 2021 | |
| Rxsight INC | $105.62 | 2022 | |
| Allergan, INC. | $100.83 | 2022 | |
| Maculogix, INC. | $72.91 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $39.25 | 2022 | |
| Oyster Point Pharma, INC. | $31.44 | 2022 | |
| Thea Pharma INC. | $20.66 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sana Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.